我院2007年11月～2008年11月精神分裂症住院患者用药情况分析  

Analysis of Drug Utilization in Inpatients with Schizophrenia in Our Hospital During Nov. 2007~Nov. 2008

作　　者：黄志军[1] 李桃[1] 赖家丽[2] 

机构地区：[1]广东省人民医院药学部/广东省医学科学院,广州市510120 [2]广东药学院,广州市510006

出　　处：《中国药房》2010年第2期106-108,共3页China Pharmacy

摘　　要：目的:评价我院住院精神分裂症患者的用药情况。方法:采用世界卫生组织推荐的限定日剂量和药物利用指数(DUI)法,对我院2007年11月～2008年11月精神分裂症住院患者的用药情况进行统计、分析。结果:用药频度(DDDs)排序列前3位是喹硫平、奥氮平、利培酮,均为非典型抗精神病药,典型抗精神病药舒必利列第17位;大部分药物的DUI<1.0。结论:我院多数精神分裂症患者用药合理,非典型抗精神病药在临床占主导地位。OBJECTIVE： To evaluate the current situation of drug utilization in inpatients with schizophrenia in our hospital. METHODS： The medication of inpatients with schizophrenia during Nov. 2007-Nov.2008 were analyzed statistically, referring to the DDD and DUI method recommended by WHO. RESULTS： Quetiapine, olanzapine, risperidone dominated the first 3 place in DDDs, which were all atypical antipsychotic drugs. Sulpiride ranked at 17th place in the list of typical antipsychotic drugs, the DUI of most drugs were lower than 1.0. CONCLUSION： The medication of most patients with schizophrenia is appropriate. Atypical antipsychotic drugs occupy a dominant position in the clinic.

关 键 词：抗精神病药 精神分裂症 限定日剂量 药物利用指数 

分 类 号：R969.3[医药卫生—药理学] R287[医药卫生—药学]